Novartis India Ltd Financials
Company Logo

Novartis India Ltd Financial Statement

Novartis India Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue97.43
Operating Expense69.14
Net Profit20.41
Net Profit Margin20.95
Earning Per Share8.27
EBIDTA29.36
Effective Tax Rate29.06

Novartis India Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual335.07
Operating Expenses Annual269.81
Operating Profit Annual126.94
Interest Annual1.49
Depreciation2.61
Net Profit Annual85.19
Tax Annual37.65

Novartis India Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning19.42
Cash Flow from Operations113.40
Cash Flow from Investing33.13
Cash Flow from Financing-120.99
Cash Flow at the End44.96

Novartis India Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)37.88
PBIT Margin (%)37.11
PBT Margin (%)12.21
Net PROFIT Margin (%)25.42
Return On Networth / Equity (%)11.21
Return On Networth /Employed (%)15.57
Return On Assets (%)10.68
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)0.42

Novartis India Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual6.94
Total Current Assets Annual699.26
Non Current Assets Annual225.67
Total Shareholders Funds Annual744.82
Total Assets Annual924.93

Novartis India Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Novartis India Ltd has a market capitalization of 2,539.57 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Novartis India Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Novartis India Ltd recorded a total revenue of approximately 335.07 Cr marking a significant milestone in the company's financial performance.
Novartis India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and -0.1% annually, respectively..
Novartis India Ltd's current PE ratio is 29.81.
Novartis India Ltd's ROCE averaged 12.7% from the FY ending March 2022 to 2024, with a median of 14.6%. It peaked at 16.5% in March 2024, reflecting strong capital efficiency over the period..
Novartis India Ltd's latest EBIT is Rs. 124.33 Cr, surpassing the average EBIT of Rs. 80.82 Cr over the 5 years..